{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:37:02Z","timestamp":1792193822174,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.clindermatol.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T08:28:20Z","timestamp":1474014500000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Palmoplantar psoriasis"],"prefix":"10.1016","volume":"35","author":[{"given":"Burhan","family":"Engin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"A\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yal\u00e7\u0131n","family":"T\u00fcz\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.09.004_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000232301","article-title":"Clinical spectrum and severity of psoriasis","volume":"38","author":"Meier","year":"2009","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0010","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaad.2008.11.910","article-title":"Palmoplantar psoriasis: a phenotypical and clinical review with introduction of a new quality-of-life assessment tool","volume":"60","author":"Farley","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0015","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(07)61129-5","article-title":"Current and future management of psoriasis","volume":"370","author":"Menter","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0020","first-page":"5","article-title":"Psoriasis and psoriasiform dermatitis","volume":"5","author":"Sezer","year":"2012","journal-title":"Turkiye Klinikleri J Dermatol Spec Top"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0025","first-page":"21","article-title":"Clinical spectrum in psoriasis","volume":"5","author":"G\u00fcr","year":"2012","journal-title":"Turkiye Klinikleri J Dermatol Spec Top"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0030","series-title":"Braun Falco\u2019s Dermatology","first-page":"506","article-title":"Psoriasis","author":"Christophers","year":"2009"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0035","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1503\/cmaj.121143","article-title":"Palmoplantar pustulosis","volume":"185","author":"Wetter","year":"2013","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0040","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.det.2013.04.001","article-title":"Autoinflammatory pustular neutrophilic diseases","volume":"31","author":"Naik","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09546631003636817","article-title":"Pustulosis palmoplantaris is a disease distinct from psoriasis","volume":"22","author":"De Waal","year":"2011","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0050","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","article-title":"Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet","volume":"156","author":"Michaelsson","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0055","first-page":"225","article-title":"Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study","volume":"85","author":"Hagforsen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0060","first-page":"14","article-title":"The skin in psoriasis: assessment and challenges","volume":"33","author":"Oji","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0065","first-page":"WC01","article-title":"Palmoplantar psoriasis\u2014ahead in the race\u2014a prospective study from a tertiary health care centre in South India","volume":"9","author":"Venkatesan","year":"2015","journal-title":"J Clin Diagn Res"},{"issue":"Suppl. 2","key":"10.1016\/j.clindermatol.2016.09.004_bb0070","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","article-title":"Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis","volume":"120","author":"Asumalahti","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0080","first-page":"8","article-title":"Psoriasis etiopathogenesis: new insights","volume":"5","author":"Senturk","year":"2012","journal-title":"Turkiye Klinikleri J Dermatol Spec Top"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0085","first-page":"311","article-title":"Anti-IL-17 agents for psoriasis: a review of phase III data","volume":"15","author":"Farahnik","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0090","series-title":"Dermatology","first-page":"745","article-title":"Psoriasis","author":"G\u00fclekon","year":"2008"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0095","first-page":"888","article-title":"The use of methotrexate, alone or in combination with other therapies, for the treatment of palmoplantar psoriasis","volume":"14","author":"Wald","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0100","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2014.04.063","article-title":"Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis","volume":"71","author":"Chung","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.12816\/0003221","article-title":"Rapid improvement of palmoplantar psoriasis after cessation of smoking","volume":"13","author":"Elahmed","year":"2013","journal-title":"Sultan Qaboos Univ Med J"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ad.2012.12.009","article-title":"Effectiveness and safety of psoralen-UVA (PUVA) topical therapy in palmoplantar psoriasis: a report on 48 patients","volume":"104","author":"Carrascosa","year":"2013","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0115","first-page":"60","article-title":"Acrodermatitis continua of hallopeau successfully treated with adalimumab","volume":"5","author":"Sopkovich","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D31CZ4R861","article-title":"Acrodermatitis continua","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0125","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jdv.13236","article-title":"Palmoplantar psoriasis, a frequent and severe clinical type of psoriasis in children","volume":"30","author":"Amode","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/0019-5154.80410","article-title":"Comparative therapeutic evaluation of different topicals and narrow band ultraviolet B therapy combined with systemic methotrexate in the treatment of palmoplantar psoriasis","volume":"56","author":"Gupta","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0135","doi-asserted-by":"crossref","first-page":"634","DOI":"10.4103\/0378-6323.72455","article-title":"Newer trends in the management of psoriasis at difficult to treat locations: scalp, palmoplantar disease and nails","volume":"76","author":"Handa","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/00015555-1273","article-title":"Living with psoriasis: prevalence of shame, anger, worry, and problems in daily activities and social life","volume":"92","author":"Sampogna","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0145","first-page":"55","article-title":"Topical treatments of psoriasis","volume":"1","author":"Duman","year":"2008","journal-title":"Turkiye Klinikleri J Dermatol Spec Top"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2012.04522.x","article-title":"Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities","volume":"26","author":"Castela","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0155","first-page":"59","article-title":"Occlusive versus nonocclusive calcipotriol ointment treatment for palmoplantar psoriasis","volume":"23","author":"Duweb","year":"2001","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0160","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1346-8138.13064","article-title":"Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Umezawa","year":"2016","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-4362.1997.00176.x","article-title":"Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle?","volume":"36","author":"Kumar","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0170","first-page":"37","article-title":"Use of topical coal tar foam for the treatment of psoriasis in difficult-to-treat areas","volume":"3","author":"Zeichner","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-5154.77550","article-title":"Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: an observer-blinded randomized controlled study","volume":"56","author":"Mehta","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3109\/15569527.2011.647182","article-title":"Psoriasis phototherapy experience from a Lisbon unit: a still valid therapeutic approach in the 21 st century","volume":"32","author":"Carvalho","year":"2013","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0185","first-page":"CD009481","article-title":"Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis","volume":"10","author":"Chen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jdv.12561","article-title":"Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion","volume":"28","author":"Sevrain","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/14651858.CD009481.pub2","article-title":"Broad-band UVB versus paint PUVA for palmoplantar psoriasis treatment","volume":"20","author":"Lozinski","year":"2015","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0200","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/dth.12086","article-title":"Acitretin","volume":"26","author":"Ortiz","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-4362.2001.01094-3.x","article-title":"Acitretin therapy for palmoplantar pustulosis combined with UVA and topical 8-MOP","volume":"40","author":"Ettler","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0210","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","article-title":"A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients","volume":"23","author":"Adi\u015fen","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0215","first-page":"3","article-title":"Treatment for chronic palmoplantar pustular psoriasis","volume":"6","author":"Marsland","year":"2001","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0220","doi-asserted-by":"crossref","DOI":"10.5070\/D3218028439","article-title":"Successful treatment of palmoplantar pustulosis with isotretinoin","volume":"21","author":"Wilken","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0225","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/bjd.14401","article-title":"Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomised Phase II study","volume":"174","author":"Reich","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0230","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2133.2012.11063.x","article-title":"Alitretinoin abrogates innate inflammation in palmoplantar hyperkeratotic psoriasis","volume":"167","author":"Irla","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0235","first-page":"45","article-title":"Successful treatment of palmoplantar hyperkeratotic psoriasis with a combination of etanercept and alitretinoin","volume":"4","author":"Meyer","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0240","first-page":"153","article-title":"Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate","volume":"94","author":"Stanford","year":"2014","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0245","first-page":"270","article-title":"Topical methotrexate therapy in palmoplantar psoriasis","volume":"65","author":"Ravi Kumar","year":"1999","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0250","doi-asserted-by":"crossref","first-page":"e384","DOI":"10.1111\/jdv.12004","article-title":"Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study","volume":"27","author":"Janagond","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1468-3083.2011.03992.x","article-title":"Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis","volume":"25","author":"Maza","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0260","first-page":"758","article-title":"A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis","volume":"20","author":"Hayama","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2230.2009.03520.x","article-title":"Therapeutic options for palmoplantar pustulosis","volume":"35","author":"Adi\u015fen","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0270","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2133.2006.07405.x","article-title":"European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey","volume":"155","author":"Dubertret","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0275","series-title":"Clinical Dermatology","author":"Habif","year":"2010"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0280","first-page":"216","article-title":"Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients","volume":"68","author":"Wong","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2008.02942.x","article-title":"308-nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasis","volume":"23","author":"Gattu","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/14764172.2011.564769","article-title":"308-nm Excimer laser treatment of palmoplantar psoriasis","volume":"13","author":"Goldberg","year":"2011","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0295","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2340\/00015555-0002","article-title":"Treatment of palmoplantar psoriasis with monochromatic excimer light (308-nm) versus cream PUVA","volume":"86","author":"Neumann","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0300","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/pho.2013.3545","article-title":"UVA-1 laser in the treatment of palmoplantar pustular psoriasis","volume":"31","author":"Nistic\u00f2","year":"2013","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0305","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s40265-015-0439-1","article-title":"Apremilast: a review in psoriasis and psoriatic arthritis","volume":"75","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0310","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bjd.13012","article-title":"Partial clinical response to anakinra in severe palmoplantar pustular psoriasis","volume":"171","author":"Tauber","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0315","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ced.12759","article-title":"Palmoplantar pustular psoriasis unresponsive to the interleukin-1 \u03b2 antagonist canakinumab","volume":"41","author":"Mansouri","year":"2016","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0320","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1529-8019.2010.01361.x","article-title":"Therapeutic hotline. Alefacept in the treatment of hyperkeratotic palmoplantar psoriasis","volume":"23","author":"Lior","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0325","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/09546630701364776","article-title":"Open label trial of alefacept in palmoplantar pustular psoriasis","volume":"19","author":"Carr","year":"2008","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0330","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2310\/7750.2007.00036","article-title":"Alefacept is safe and efficacious in the treatment of palmar plantar pustulosis","volume":"11","author":"Guenther","year":"2007","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0335","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1468-3083.2011.03984.x","article-title":"Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study","volume":"25","author":"Bissonnette","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D345C3P0NH","article-title":"Adalimumab in the management of palmoplantar psoriasis","volume":"15","author":"Ghate","year":"2009","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0345","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2340\/00015555-1540","article-title":"Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau","volume":"93","author":"Dini","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0350","first-page":"247","article-title":"Tumor necrosis factor-a inhibition and palmoplantar pustulosis: Janus-faced therapy?","volume":"34","author":"Dutz","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000345468","article-title":"Improvement of anti-TNF-\u03b1 antibody-induced palmoplantar pustular psoriasis using a 308-nm excimer light","volume":"4","author":"Iga","year":"2012","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0360","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2217\/imt.15.45","article-title":"Palmoplantar pustular psoriasis induced by adalimumab: a case report and literature review","volume":"7","author":"Ibis","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0365","doi-asserted-by":"crossref","first-page":"413767","DOI":"10.1155\/2012\/413767","article-title":"Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease","volume":"2012","author":"Hermanns-Le","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.clindermatol.2016.09.004_bb0370","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000320961","article-title":"Efficacy of ustekinumab in palmoplantar psoriasis","volume":"221","author":"Bulai Livideanu","year":"2010","journal-title":"Dermatology"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T19:13:59Z","timestamp":1749582839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16302231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0738081X16302231"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.09.004","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palmoplantar psoriasis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}